Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IFN-alpha/beta R1 Antibody (85228), DyLight 350, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals FAB245D

Catalog No. NB365060


Only null left
Add to Cart

Description

Description

IFN-alpha/beta R1 Monoclonal antibody specifically detects IFN-alpha/beta R1 in Human samples. It is validated for Western Blot, Flow Cytometry, CyTOF
Specifications

Specifications

IFN-alpha/beta R1
Monoclonal
DyLight 350
50mM Sodium Borate
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
Primary
Human
Purified
Western Blot, Flow Cytometry, CyTOF
85228
Western Blot, Flow Cytometry, CyTOF-ready
alpha-type antiviral protein, AVP, beta-type antiviral protein, CRF2-1, Cytokine receptor class-II member 1, Cytokine receptor family 2 member 1, human interferon-alpha receptor (HuIFN-alpha-Rec)10IFRC, IFN-alpha/beta receptor 1, IFN-alpha-REC, IFNAR, IFNBR, IFN-R-1, interferon (alpha, beta and omega) receptor 1, interferon alpha/beta receptor 1, interferon-alpha/beta receptor alpha chain, interferon-beta receptor 1, Type I interferon receptor 1
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human IFN-alpha/beta R1, Lys28-Lys436, Accession # AAA52730
0.1 mL
Neuroscience
3454
Store at 4°C in the dark.
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.